These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring. Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833 [TBL] [Abstract][Full Text] [Related]
24. [Disopyramide in heart arrhythmias]. Pellegrino L; Di Michele A; Prencipe D Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948 [No Abstract] [Full Text] [Related]
25. [Disopyramide in the prevention of arrhythmia following myocardial infarction and resistant arrhythmia]. Dallocchio M; Daubeze J; Clementy J; Poisot D; Bricaud H; Broustet P Therapie; 1974; 29(1):119-29. PubMed ID: 4848509 [No Abstract] [Full Text] [Related]
26. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods. Kimura E; Mashima S; Tanaka T Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic value of Rhytmodan in the management of ectopic arrhythmias]. Woyda J Pol Tyg Lek; 1972 Dec; 27(50):1985-8. PubMed ID: 4649232 [No Abstract] [Full Text] [Related]
28. Disopyramide (Norpace) for ventricular arrhythmias. Med Lett Drugs Ther; 1977 Dec; 19(25):101-2. PubMed ID: 593226 [No Abstract] [Full Text] [Related]
29. Chronic ventricular arrhythmias: comparative drug effectiveness and toxicity. Warnowicz MA; Denes P Prog Cardiovasc Dis; 1980; 23(3):225-36. PubMed ID: 6107955 [No Abstract] [Full Text] [Related]
30. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases. Dhurandhar RW; Nademanee K; Goldman AM Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503 [TBL] [Abstract][Full Text] [Related]
36. Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction. Zainal N; Jennings G; Jones B; Model D; Turner P; Besterman EM; Kidner PH J Int Med Res; 1976; 4(1 Suppl):71-3. PubMed ID: 799982 [No Abstract] [Full Text] [Related]
37. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents. Ellrodt G; Singh BN Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519 [No Abstract] [Full Text] [Related]
38. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise]. Cardonne A; Pérez-Medina T; García-Barreto D Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692 [TBL] [Abstract][Full Text] [Related]
39. [Disopyramide: a new anti-arrhythmia drug. Clinical trials]. Poletti T; Aquaro G; D'Arrigo A Minerva Med; 1970 Jun; 61(48):2678-95. PubMed ID: 5428155 [No Abstract] [Full Text] [Related]
40. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias]. Cosnier D; Grimal J; Duchene-Marullaz P Therapie; 1971; 26(1):97-107. PubMed ID: 5554772 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]